All announcements

$20 million boost for development of antiviral drugs against pandemic influenza
The Pandemic Antiviral Discovery (PAD) initiative is funding 11 research projects around the world to facilitate early-stage development of novel antiviral drugs to treat potential future outbreaks of pandemic influenza. The projects are receiving a total of $20 million.

International Conference on Antiviral Research (ICAR) 2024
The PAD initiative sponsors ICAR 2024

Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics
Fourteen research projects will focus on antiviral research and drug development for henipaviruses, a subgroup of viruses with pandemic potential.

International Conference on Antiviral Research (ICAR) 2023
The PAD initiative sponsors ICAR

Call Closed
The ‘PAD Request for Proposals’ focused on Antivirals for Pandemic Influenza closed on 14 December 2022.

Antivirals for Pandemic Influenza – Request for proposals 2022/2023
The focus of this PAD Request for Proposals (RfP) is novel antivirals for pandemic influenza. Pandemic influenza remains is a substantial threat to public health. There have been six major influenza epidemics with the 1918 flu pandemic being the most severe, leading to the deaths of 50–100 million people worldwide. There is a need for cheap and safe antiviral compounds that target viral/host proteins and pathways necessary for replication and pathogenesis that are clearly differentiated from currently marketed drugs for seasonal influenza.